Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection.

Lung-Yi MakDanny Ka-Ho WongKa-Shing CheungRex Wan-Hin HuiFen LiuJames FungWai-Kay SetoMan Fung Yuen

Published in: Digestive diseases and sciences (2022)

Persistent advanced fibrosis or cirrhosis was observed in two-thirds of CHB patients despite potent antiviral therapy. High serum M2BPGi and central obesity were associated with more than twofold and fourfold increase in risk of persistent advanced fibrosis or cirrhosis, respectively.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
insulin resistance
type diabetes
weight loss
prognostic factors
liver fibrosis
stem cells
weight gain
mesenchymal stem cells
bone marrow
adipose tissue
cell therapy
chemotherapy induced